Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients

This study has been terminated.
(Lack of patients to enroll.)
Sponsor:
Information provided by (Responsible Party):
Eisai Inc. ( Eisai Korea Inc. )
ClinicalTrials.gov Identifier:
NCT00165750
First received: September 12, 2005
Last updated: November 19, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2008
  Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)